U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
VARLILUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
varlilumab [INN]
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER
Common Name English
CDX-1127
Code English
VARLILUMAB [USAN]
Common Name English
Varlilumab [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
Code System Code Type Description
INN
9933
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
WIKIPEDIA
Varlilumab
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
CAS
1393344-72-3
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
USAN
AB-79
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
FDA UNII
0125DUV5XC
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
SMS_ID
100000170621
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
EVMPD
SUB184654
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
NCI_THESAURUS
C99127
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
ChEMBL
CHEMBL3137347
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
DRUG BANK
DB11930
Created by admin on Tue Apr 01 16:23:34 GMT 2025 , Edited by admin on Tue Apr 01 16:23:34 GMT 2025
PRIMARY
ACTIVE MOIETY
VARLILUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966